Login : Register
>> All Sectors >> Healthcare >> Drugs >> Drug Manufacturers/Other >> AGN

Company Information for Allergan, Incorporated

Ockham Research Recent Fundamental Reports on
AGN - Allergan, Incorporated
Report Link Report Type Report Date Score / Rating
View Ockham Fundamental Research Report on AGN - Allergan, Incorporated Reiteration 07/19/2008 11:07 A 2 / Positive
View Ockham Fundamental Research Report on AGN - Allergan, Incorporated Rating Change 07/12/2008 03:29 P 2 / Positive
View Ockham Fundamental Research Report on AGN - Allergan, Incorporated Reiteration 07/05/2008 11:04 A 1 / Very Positive
View Ockham Fundamental Research Report on AGN - Allergan, Incorporated Rating Change 06/28/2008 11:09 A 1 / Very Positive
Ockham Research Fundamental Stock Reports for AGN - Allergan, Incorporated: Price Volume Chart
AGN - Allergan, Incorporated Fundamentals
Price $52.03 as of 07/22/2008
Volume 18,162
10 Day Average Volume 22,881
13 Week Price Range $50.21 - $59.90
52 Week Price Range $50.21 - $70.40
Last Twelve Month (LTM) Revenue $4.1 Billion
 
Shares Outstanding 305.0 Million as of 05/02/2008
Market Capitalization $15.9 Billion
Shares Held By Institutions 291.5 Million
Number of Institutions Holding Shares 645
% Shares Held By Institutions 95.6%
Earnings Per Share (EPS) $1.62 as of 12/2007
P/E Ratio 28.3
Book Value Per Share $12.55
 
Gross Margin 85.4
Dividend Rate .20
Dividend Yield .4
Beta 1.09
Fiscal Year Ends December
 
ABOUT ALLERGAN, INCORPORATED
Allergan, Incorporated is considered to operate in the Healthcare sector. They specifically operate in the Drug Manufacturers/Other business segment contained within the Drugs industry.
A health care company, which focused on developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to see more clearly, move more freely and express themselves more fully.